The thermal decomposition of titanomagnetite-based ironsand, and the effects of ironsand addition on the formation of SFCA and SFCA-I iron ore sinter bonding phases, was investigated using in situ X-ray diffraction. Titanium incorporation into the SFCA and SFCA-I structures was investigated via phase equilibria experiments and subsequent ex situ characterisation. Increasing ironsand addition from 1.3 to 6.7 and to 13.8 mass% in an otherwise synthetic sinter mixture composition designed to form SFCA-I did not significantly affect the thermal stability range of SFCA-I (~1 373-1 523 K), nor did it significantly affect the maximum concentration of SFCA-I attained (42-46 mass%). The main effect of ironsand addition was a small reduction in the thermal stability range of another complex calcium-rich ferrite, γ-CFF. In comparison, increasing ironsand addition from 2.4 to 3.9 and to 11.6 mass% in an otherwise synthetic sinter mixture composition designed to form SFCA resulted in a decrease in the maximum SFCA-I concentration, from 30, to 24 and 16 mass%, respectively, with a corresponding increase in the concentration of SFCA (16, to 23 and 33 mass%). The phase equilibria studies revealed that SFCA can incorporate more titanium in its structure (up to 1.2 mass% TiO 2 ) than SFCA-I (0.6 mass% TiO 2 ). The 'total SFCA' (i.e. SFCA-I + SFCA) content decreased as the ironsand content increased, as well as there being a general shift to higher temperature of the total SFCA concentration curves. Such effects are likely to exert an influence on the physical properties of iron ore sinter, as well as affecting sintering fuel requirements.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.